"False"
Umeå universitet
printicon
Huvudmenyn dold.
Personalbild Lars Hjalmar Lindholm

Lars Hjalmar Lindholm

Vetenskaplig meritering: Docent

Kontakt

E-post
lars.h.lindholm@umu.se
Telefon
090-786 73 32

Verksam vid

Anknytning
Professor vid Institutionen för folkhälsa och klinisk medicin Enhet: Allmänmedicin
Plats
5B Målpunkt PA, NUS Försörjningsvägen 7E, 7016 UmU, Allmänmedicin, 901 85 Umeå
Association of education and feedback on hypertension management with risk for stroke and cardiovascular disease
Blood Pressure, Taylor & Francis Group 2022, Vol. 31, (1) : 31-39
Brunström, Mattias; Ng, Nawi; Dahlström, John; et al.
Postpartum quality of life in Indian women after vaginal birth and cesarean section: a pilot study using the EQ-5D-5L descriptive system
BMC Pregnancy and Childbirth, BioMed Central 2018, Vol. 18
Kohler, Stefan; Annerstedt, Kristi Sidney; Diwan, Vishal; et al.
Framgång för den nationella forskarskolan i allmänmedicin: nu finns förutsättningar för svensk allmänmedicinsk forskning att bli internationellt konkurrenskraftig: [Success for the national research school in general medicine]
Läkartidningen, Läkartidningen förlag AB 2017, Vol. 114, (35-36)
Griffin, Simon; Lindholm, Lars H.; Spencer, Stuart
From efficacy in trials to effectiveness in clinical practice: The Swedish Stroke Prevention Study
Blood Pressure, Vol. 25, (4) : 206-211
Brunström, Mattias; Dahlström, John; Lindholm, Lars Hjalmar; et al.
Blood pressure variability predicts cardiovascular events independently of traditional cardiovascular risk factors and target organ damage: a LIFE substudy
Journal of Hypertension, Lippincott Williams & Wilkins 2015, Vol. 33, (12) : 2422-2430
Vishram, Julie K.K.; Dahlöf, Björn; Devereux, Richard B.; et al.
The new Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014): a giant undertaking
Hypertension Research, Nature Publishing Group 2014, Vol. 37, (4) : 391-392
Lindholm, Lars H.; Carlberg, Bo
Nationell forskarskola har global räckvidd: både vetenskapligt och geografiskt når doktoranderna långt
Läkartidningen, Sveriges läkarförbund 2014, Vol. 111, (15)
Lindholm, Lars H; Spencer, Stuart
A prediction of the renal and cardiovascular efficacy of aliskiren in ALTITUDE using short-term changes in multiple risk markers
European Journal of Preventive Cardiology, Vol. 21, (4) : 434-441
Smink, P. A.; Hoekman, J.; Grobbee, D. E.; et al.
Clinical Practice Guidelines for the Management of Hypertension in the Community A Statement by the American Society of Hypertension and the International Society of Hypertension
Journal of Hypertension, Lippincott Williams & Wilkins 2014, Vol. 32, (1) : 3-15
Weber, Michael A.; Schiffrin, Ernesto L.; White, William B.; et al.
Clinical practice guidelines for the management of hypertension in the community a statement by the American society of hypertension and the International society of hypertension
The Journal of Clinical Hypertension, John Wiley & Sons 2014, Vol. 16, (1) : 14-26
Weber, Michael A; Schiffrin, Ernesto L; White, William B; et al.
In-treatment HDL cholesterol levels and development of new diabetes mellitus in hypertensive patients: the LIFE study
Diabetic Medicine, Vol. 30, (10) : 1189-1197
Okin, PM; Hille, DA; Wiik, BP; et al.
β-blockers in hypertension
Hypertension: a companion to Braunwald's heart disease, Saunders Elsevier 2012 : 172-178
Carlberg, Bo; Frishman, William H.; Lindholm, Lars H
The relationship of electrocardiographic left ventricular hypertrophy to decreased serum potassium
Blood Pressure, Vol. 21, (3) : 146-152
Okin, Peter M.; Kjeldsen, Sverre E.; Lindholm, Lars H.; et al.
Losartan versus atenolol-based antihypertensive treatment reduces cardiovascular events especially well in elderly patients: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study
Journal of Hypertension, Vol. 30, (6) : 1252-1259
Ruwald, Anne Christine H.; Westergaard, Bo; Sehestedt, Thomas; et al.
Blood-pressure drugs and cancer: much ado about nothing?
The Lancet Oncology, Vol. 12, (1) : 6-8
Lindholm, Lars H; Carlberg, Bo
Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy
Journal of Hypertension, Vol. 29, (5) : 997-1004
Olsen, Michael H.; Wachtell, Kristian; Ibsen, Hans; et al.
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals The ARB Trialists Collaboration
Journal of Hypertension, Vol. 29, (4) : 623-635
Teo, Koon K.; Sleight, Peter; Gao, Peggy; et al.
Divergent results using clinic and ambulatory blood pressures report of a darusentan-resistant hypertension trial
Hypertension, Vol. 56, (5) : 824-830
Bakris, George L; Lindholm, Lars H; Black, Henry R; et al.
Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials.
Journal of Hypertension, Vol. 28, (7) : 1366-1372
Bejan-Angoulvant, Theodora; Saadatian-Elahi, Mitra; Wright, James M; et al.
Comment: Stroke and blood-pressure variation: new permutations on an old theme.
The Lancet, Elsevier 2010, Vol. 375, (9718) : 867-869
Carlberg, Bo; Lindholm, Lars Hjalmar
Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The Losartan intervention for endpoint reduction in hypertension study
Journal of Hypertension, Vol. 28, (6) : 1134-1140
Cicala, Silvana; de Simone, Giovanni; Gerdts, Eva; et al.
International Society of Hypertension Low and Middle Income Countries Committee Review of the Goals of the Committee and of 5 years of ISH activities in Low and Middle Income Countries
Journal of Hypertension, Lippincott Williams & Wilkins, Inc. 2010, Vol. 28, (3) : 635-636
Fagard, R H; Grassi, G; Hall, J; et al.
Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients
American Journal of Hypertension, Vol. 23, (7) : 786-793
Okin, Peter M; Hille, Darcy A; Kjeldsen, Sverre E; et al.
An endothelin antagonist for resistant hypertension: authors' reply
The Lancet, Vol. 375, (9715) : 636-637
Weber, Michael A; Linseman, Jennifer V; Lindholm, Lars H
Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: The LIFE study
American Journal of Hypertension, Nature Publishing Group 2010, Vol. 23, (8) : 845-851
Wiik, Benedicte P.; Larstorp, Anne C.K.; Höieggen, Aud; et al.
Beta blockers reduce left ventricular mass less than other antihypertensive drugs: a systematic review and meta analysis
Journal of Hypertension, Vol. 27, (Suppl. 4) : s319-s319
Hedblad, B; Melander, H; de Faire, U; et al.
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the losartan inventervention for endpoint reduction in hypertension study
Blood Pressure, Vol. 18, (6) : 348-361
Kjeldsen, Sverre E; Devereux, Richard B; Hille, Darcy A; et al.
Darusentan treatment significantly decreases blood pressure and results in better systolic blood pressure control when added to multi-drug therapy in patients with resistant hypertension
Journal of Human Hypertension, Vol. 23, (10) : 697-697
Lindholm, Lars H; Black, HR; Bakris, GL; et al.
Darusentan lowers blood pressure significant on top of multi-drug treatment in patients with resistant hypertension
Journal of Hypertension, Vol. 27, (Suppl. 4) : s167-s168
Lindholm, Lars H; Black, HR; Bakris, GL; et al.
Association of hypokalemia with Cornell product left ventricular hypertrophy independant of treatment and blood pressure in hypertensive patients: implications for the development of new diurectic anthihypertensives
Journal of the American College of Cardiology, Vol. 53, (10: suppl 1) : 211-211
Okin, Peter M; Kjeldsen, Sverre E; Lindholm, Lars H; et al.
Competing effects of hypokalemia and hydrochlororothiazide treatment  on regression of Cornell product left ventricular hypertrophy  in hypertensive patients: implications for the development of potassium-sparing diuretics
Circulation, Vol. 120, (Suppl. 18) : s1015-s1015
Okin, Peter M; Kjeldsen, Sverre; Lindholm, Lars H; et al.
The relationship of in-treatment serum glucose to all-cause mortality and cardiovascular morbidity and mortality in hypertensive patients without known diabetic during treatment: the LIFE study
Hypertension, Lipids and Prevention: Abstracts of Original Contributions - Presented at the American College of Cardiology , Elsevier 2009 : A218-A218
Okin, PM; Devereux, RB; Hille, DA; et al.
Prognostic importance of haemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: The losartan intervention for end point reduction in hypertension (LIFE) study
American Heart Journal, Elsevier 2009, Vol. 157, (1) : 177-184
Olsen, Michael Hecht; Wachtell, Kristian; Beevers, Gareth; et al.
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the losartan intervention for endpoint reduction in hypertension (LIFE) study
Journal of Hypertension, Vol. 27, (3) : 567-574
Olsen, Michael Hecht; Wachtell, Kristian; Beevers, Gareth; et al.
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, Elsevier 2009, Vol. 374, (9699) : 1423-1431
Weber, Michael A; Black, Henry; Bakris, George; et al.
Blood-pressure-related disease is a global health priority.
The Lancet, London: 2008, Vol. 371, (9623) : 1480-1482
MacMahon, Stephen; Alderman, Michael H.; Lindholm, Lars H; et al.
Blood-pressure-related disease is a global health priority
American Journal of Hypertension, New York: Elsevier 2008, Vol. 21, (8) : 843-844
Macmahon, Stephen; Alderman, Michael H.; Lindholm, Lars Hjalmar; et al.
Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE study.
Am J Hypertens, Vol. 21, (3) : 273-9
Okin, Peter M; Wachtell, Kristian; Devereux, Richard B; et al.
Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study
Circulation - Arrhythmia and Electrophysiology, Vol. 1, (5) : 337-343
Okin, Peter M; Wachtell, Kristian; Kjeldsen, Sverre E; et al.
Systolic pressure is all that matters.
Lancet, Vol. 371, (9631) : 2219-2221
Williams, B; Lindholm, Lars H; Sever, P
Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Current Medical Research and Opinion, Taylor & Francis 2007, Vol. 23, (2) : 259-70
Devereux, Richard B; de Faire, Ulf; Fyhrquist, Frej; et al.
Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studies.
Journal of Hypertension, Vol. 25, (4) : 871-6
Eijkelkamp, Wouter B A; Zhang, Zhongxin; Brenner, Barry M; et al.
Prevention of cardiovascular disease in developing countries.
The Lancet, Elsevier 2007, Vol. 370, (9589) : 720-2
Lindholm, Lars H; Mendis, Shanthi
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Journal of Hypertension, Wolters Kluwer 2007, Vol. 25, (6) : 1105-87
Mancia, Giuseppe; De Backer, Guy; Dominiczak, Anna; et al.
2007 Guidelines for the management of arterial hypertension: The task gorce for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
European Heart Journal, Philadelphia: W.B. Saunders 2007, Vol. 28, (12) : 1462-536
Mancia, Giuseppe; De Backer, Guy; Dominiczak, Anna; et al.
[Practice guidelines 2007 for the treatment of arterial hypertension]
G Ital Cardiol (Rome), Vol. 8, (7) : 389-479
Mancia, Giuseppe; De Backer, Guy; Dominiczak, Anna; et al.
ESH/ESC 2007 Guidelines for the management of arterial hypertension
Revista Española de Cardiología, Madrid: Paz Montalvo 2007, Vol. 60, (9) : 968.e1-94
Mancia, Guiseppe; De Backer, Guy; Dominiczak, Anna; et al.
World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries.
Journal of Hypertension, Wolters Kluwer 2007, Vol. 25, (8) : 1578-82
Mendis, Shanthi; Lindholm, Lars H; Mancia, Giuseppe; et al.
In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study.
Hypertension, Vol. 50, (5) : 984-90
Okin, Peter M; Devereux, Richard B; Harris, Katherine E; et al.
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study
Circulation, Lippincott Williams & Wilkins 2007, Vol. 116, (7) : 700-705
Wachtell, Kristian; Okin, Peter M; Olsen, Michael H; et al.
Visa publikationer i DiVA
Logotyp Nationella forskarskolan i allmänmedicin
Nationella forskarskolan i allmänmedicin

Extern hemsida.